- Company Overview for AXALBION THERAPEUTICS LIMITED (13224059)
- Filing history for AXALBION THERAPEUTICS LIMITED (13224059)
- People for AXALBION THERAPEUTICS LIMITED (13224059)
- Charges for AXALBION THERAPEUTICS LIMITED (13224059)
- More for AXALBION THERAPEUTICS LIMITED (13224059)
- Registered office address
- C/O Medicines Evaluation Unit, The Langley Building, Southmoor Road, Wythenshawe, Manchester, United Kingdom, M23 9QZ
- Company status
- Active
- Company type
- Private limited Company
- Incorporated on
- 24 February 2021
Accounts
Next accounts made up to 31 December 2023
due by
30 September 2024
Last accounts made up to 31 December 2022
Confirmation statement
Next statement date 6 June 2024
due by 20 June 2024
Last statement dated 6 June 2023
Nature of business (SIC)
- 21100 - Manufacture of basic pharmaceutical products